Literature DB >> 2276383

Changing patterns of antihypertensive drug use in a German population between 1984 and 1987. Results of a population based cohort study in the Federal Republic of Germany.

H W Hense1, P Tennis.   

Abstract

In the MONICA Augsburg project, a cohort of 3324 men and women randomly selected from the population (aged 30 to 64 y) was surveyed in 1984/85 and in 1987/88. Their antihypertensive medication as well as their demographic characteristics, blood pressure values, and awareness of hypertension were assessed at each visit in an identical manner. In 1984/85 the prevalence of antihypertensive drug use in the cohort was 7.8% (n = 260). In 1987/88, 204 of the hypertensives were still being treated (continuously treated hypertensives) and there were 167 newly treated hypertensives, thus increasing the prevalence of antihypertensive drug use to 11.2%. Of the 204 continuously treated hypertensives, 45.6% had changed their antihypertensive medication over the three-year follow-up period. Combinations with diuretics (except those containing calcium antagonists or ACE-inhibitors) had largely been discontinued, and the prevalence of calcium antagonist mono- and combination therapy had markedly increased from 84/85 to 87/88. Men were treated more frequently with recently introduced antihypertensive agents than women. Newly treated hypertensives (n = 167) showed antihypertensive treatment patterns reflecting the changes observed in continuously treated hypertensives. Triple drug combinations, mostly in fixed ratios, were being taken by approximately 25% of all hypertensives at each visit. Prospective analysis revealed an underlying discontinuation rate of 49%. It is concluded that the epidemiology of antihypertensive therapy in individuals and in the community is subject to rapid changes and various influences. Cohort studies of treated antihypertensive individuals offer a more comprehensive understanding of its determinants.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2276383     DOI: 10.1007/bf02657047

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1988-05

2.  Recording of drug prescriptions in the county of Jämtland, Sweden. I. Methodological aspects.

Authors:  G Boethius; F Wiman
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

3.  The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators.

Authors: 
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

4.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

5.  Patterns in drug utilization--national and international aspects: antihypertensive drugs.

Authors:  I Baksaas
Journal:  Acta Med Scand Suppl       Date:  1984

Review 6.  Modification of stepped care approach to antihypertensive therapy.

Authors:  J H Laragh
Journal:  Am J Med       Date:  1984-08-20       Impact factor: 4.965

7.  Drug utilization - theory and practice. The present situation in the Federal Republic of Germany.

Authors:  F Gross
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

8.  The cardiovascular risk factor profile in the study area Augsburg. Results from the first MONICA survey 1984/85.

Authors:  U Keil; J Stieber; A Döring; L Chambless; U Härtel; B Filipiak; H W Hense; M Tietze; J G Gostomzyk
Journal:  Acta Med Scand Suppl       Date:  1988

9.  The treatment of hypertension--an analysis of drug prescription data.

Authors:  G Boethius
Journal:  Acta Med Scand Suppl       Date:  1976

10.  Therapeutic traditions in Northern Ireland, Norway and Sweden: II. Hypertension. WHO Drug Utilization Research Group (DURG).

Authors:  K Griffiths; D G McDevitt; M Andrew; I Baksaas; A Helgeland; J Jervell; P K Lunde; K Oydvin; I Agenäs; U Bergman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more
  2 in total

1.  European postmarketing surveillance of ramipril in hypertension. 1. Feasibility and study cohort.

Authors:  D H Lawson; K Bridgman; G H de Bock; D E Grobbee; H W Hense; P Block; K R Paterson; P Stonier
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

2.  Cardiovascular medication utilization and adherence among adults living in rural and urban areas: a systematic review and meta-analysis.

Authors:  Gaetanne K Murphy; Finlay A McAlister; Daniala L Weir; Lisa Tjosvold; Dean T Eurich
Journal:  BMC Public Health       Date:  2014-06-02       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.